Effects of glucocorticoids on antitumor effects of immunizations with fusions of dendritic and tumor cells

Anticancer Research

Volumn 23, Issue 3 B, 2003, Pages 2553-2558

  Takagi, Yuko ^a   Kikuchi, Tetsuro ^a   Niimura, Michihito ^a   Ohno, Tsuneya ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dendritic cells; Dexamethasone; Fusion; Immunotherapy; Steroid

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; CELL MARKER; GLUCOCORTICOID;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CELL FUSION; CONTROLLED STUDY; DENDRITIC CELL; DRUG EFFECT; FEMALE; GLIOMA CELL; IMMUNIZATION; IN VIVO STUDY; MOUSE; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; TUMOR CELL; TUMOR GROWTH;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; CANCER VACCINES; DEXAMETHASONE; FEMALE; GLIOMA; IMMUNIZATION; IMMUNOPHENOTYPING; IMMUNOTHERAPY, ADOPTIVE; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; PHAGOCYTOSIS; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0042306460     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Banchereau J and Steinman RM: Dendritic cells and the control of immunity. Nature 392: 245-52, 1998.
2. Nestle FO, Alijagic S, Gilliet M, Sun Y, Grabbe S, Dummer R, Burg G and Schadendorf D: Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med 4: 328-32, 1998.
3. Holtl L, Rieser C, Papesh C, Ramoner R, Herold M, Klocker H, Radmayr C, Stenzl A, Bartsch G and Thurnher M: Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells. J Urol 161: 777-82, 1999.
4. Morse MA, Deng Y, Coleman D, Hull S, Kitrell-Fisher E, Nair S, Schlom J, Ryback ME and Lyerly HK: A Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen. Clin Cancer Res 5: 1331-8, 1999.
5. Akasaki Y, Kikuchi T, Homma S, Abe T, Kufe D and Ohno T: Antitumor effect of immunizations with fusions of dendritic and glioma cells in a mouse brain tumor model. J Immunother 24: 106-13, 2001.
6. Gong J, Chen D, Kashiwaba M and Kufe D: Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells. Nat Med 3: 558-61, 1997.
7. Wang J, Saffold S, Cao X, Krauss J and Chen W: Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines. J Immunol 161: 5516-24, 1998.
8. Lespagnard L, Mettens P, Verheyden AM, Tasiaux N, Thielemans K, van Meirvenne S, Geldhof A, De Baetselier P, Urbain J, Leo O and Moser M: Dendritic cells fused with mastocytoma cells elicit therapeutic antitumor immunity. Int J Cancer 76: 250-8, 1998.
9. Kikuchi T, Akasaki Y, Irie M, Homma S, Abe T and Ohno T: Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells. Cancer Immunol Immunother 50: 337-44, 2001.
10. Homma S, Toda G, Gong J, Kufe D and Ohno T: Preventive antitumor activity against hepatocellular carcinoma (HCC) induced by immunization with fusions of dendritic cells and HCC cells in mice. J Gastroenterol 36: 764-71, 2001.
11. Kugler A, Stuhler G, Walden P, Zoller G, Zobywalski A, Brossart P, Trefzer U, Ullrich S, Muller CA, Becker V, Gross AJ, Hemmerlein B, Kanz L, Muller GA and Ringert RH: Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids. Nat Med 6: 332-6, 2000.
12. Wilckens T and De Rijk R: Glucocorticoids and immune function: unknown dimensions and new frontiers. Immunol Today 18: 418-24, 1997.
13. Woltman AM, Massacrier C, de Fijter JW, Caux C and van Kooten C: Corticosteroids prevent generation of CD34+-derived dermal dendritic cells but do not inhibit Langerhans cell development. J Immunol 168: 6181-8, 2002.
14. Rea D, van Kooten C, van Meijgaarden KE, Ottenhoff TH, Melief CJ and Offringa R: Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10. Blood 95: 3162-7, 2000.
15. Moser M, De Smedt T, Sornasse T, Tielemans F, Chentoufi AA, Muraille E, Van Mechelen M, Urbain J and Leo O: Glucocorticoids down-regulate dendritic cell function in vitro and in vivo. Eur J Immunol 25: 2818-24, 1995.
16. Kitajima T, Ariizumi K, Bergstresser PR and Takashima A: A novel mechanism of glucocorticoid-induced immune suppression: the inhibiton of T cell-mediated terminal maturation of a murine dendritic cell line. J Clin Invest 98: 142-7, 1996.
17. Vieira PL, Kalinski P, Wierenga EA, Kapsenberg ML and de Jong EC: Glucocorticoids inhibit bioactive IL-12p70 production by in vitro-generated human dendritic cells without affecting their T cell stimulatory potential. J Immunol 161: 5245-51, 1998.
18. Sakamoto K, Hoshino H, Kiuchi Y, Nakano G and Nagamachi Y: Potential usefulness of a cultured glioma cell line induced by Rous sarcoma virus in B10. A mouse as an immunotherapy model. Jpn J Exp Med 59: 173-80, 1989.
19. Wu CY, Fargeas C, Nakajima T and Delespesse G: Glucocorticoids suppress the production of interleukin 4 by human lymphocytes. Eur J Immunol 21: 2645-7, 1991.
20. Verhoeven GT, Van Haarst JM, De Wit HJ, Simons PJ, Hoogsteden HC and Drexhage HA: Glucocorticoids hamper the ex vivo maturation of lung dendritic cells from their low autofluorescent precursors in the human bronchoalveolar lavage: decreases in allostimulatory capacity and expression of CD80 and CD86. Clin Exp Immunol 122: 232-40, 2000.
21. Shodell M and Siegal FP: Corticosteroids depress IFN-alpha-producing plasmacytoid dendritic cells in human blood. J Allergy Clin Immunol 108: 446-8, 2001.
22. Woltman AM, de Fijter JW, Kamerling SW, Paul LC, Daha MR and van Kooten C: The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. Eur J Immunol 30: 1807-12, 2000.
23. de Jong EC, Vieira PL, Kalinski P and Kapsenberg ML: Corticosteroids inhibit the production of inflammatory mediators in immature monocyte-derived DC and induce the development of tolerogenic DC3. J Leukoc Biol 66: 201-4, 1999,
24. Vanderheyde N, Verhasselt V, Goldman M and Willems F: Inhibition of human dendritic cell functions by methylprednisolone. Transplantation 67: 1342-7, 1999.
25. Matasic R, Dietz AB and Vuk-Pavlovic S: Dexamethasone inhibits dendritic cell maturation by redirecting differentiation of a subset of cells. J Leukoc Biol 66: 909-14, 1999.
26. Piemonti L, Monti P, Allavena P, Sironi M, Soldini L, Leone BE, Socci C and Di Carlo V: Glucocorticoids affect human dendritic cell differentiation and maturation. J Immunol 162: 6473-81, 1999.